ICRP ref: 4824-3443-3621
Released November 16, 2017

Second Announcement

Joint ICRP-RERF-JHPS Workshop on
Recent Progress in Radiation Dosimetry for Epidemiology andRadiological Protection
The University of Tokyo
Saturday, December 2, 2017
Organised by the International Commission on Radiological Protection (ICRP), Radiation
Effect Research Foundation (RERF), and Japan Health Physics Society (JHPS)
Co-organised by Japanese Society of Radiation Safety Management (JRSM)

Objectives
Radiation dosimetry plays an important role in radiological protection and epidemiologicalstudies. In this joint ICRP-RERF-JHPS workshop co-organised by JRSM, recent developments
on radiation dosimetry will be discussed. Additionally, recent studies on atomic bomb
survivors as well as the challenges in environmental remediation after medical incidents andthe Fukushima nuclear accident will be also reported.

Registration
Advance registration is required for the preparation of presentation materials. The registration
fees to be paid onsite are 2,000 JPY for official members of JHPS and/or JRSM, 1,000 JPY forstudent members, and 4,000 JPY for non-members. Please send your name, affiliation, and email address to the Secretary of Japan Health Physics Society at exec.off@jhps.or.jp by 30
November 2017.

Venue
Room number 221, Faculty of Engineering Build. 2, Hongo Campus, The University of Tokyo
Access: http://www.t.u-tokyo.ac.jp/foee/access.html

Page 1 of 9

Program

13:30 – 13:40: Opening Addressby Hiroko Yoshida (JHPS)

13:40 – 16:50: Scientific Session
Chair: John Harrison (ICRP), Michiaki Kai (JHPS/ICRP)
Speaker:
1. Harry Cullings (RERF)
DS02R1: new dose estimates in use for the latest LSS studies
2. Wesley Bolch (ICRP)
Modern phantoms and their applications
3. John Harrison (ICRP)
Dosimetric quantities and risk
(15:10 – 15:20: Coffee break)
4. Daiki Satoh (ICRP)
External doses to the public from contaminated land
5. Yusuke Koba (JHPS)
CT dosimetric calculator
6. Kentaro Manabe (JHPS)
Modeling of internal dose from an insoluble cesium

16:50 – 17:00: Closing Remarks
by John Harrison (ICRP)

Page 2 of 9

Abstracts

Page 3 of 9

Joint ICRP-RERF-JHPS Workshop | December 2, 2017 | Tokyo(1) DS02R1: new dose estimates in use for the latest RERF studies
H.M. Cullings
Radiation Effects Research Foundation, 5-2, Hijiyama Park, Minami-ku, Hiroshima City, 732-0815 Japan; e-mail:hcull@rerf.or.jp

Abstract–The dose estimates for the atomic bomb survivors followed by RERF have been calculated by aseries of “dosimetry systems” created over the years by outside scientific groups, of which the mostrecent is Dosimetry System 2002 (DS02). DS02 calculates the source terms of prompt and delayed
neutrons and gamma rays emanating from the bombs as fluences: numbers of radiations per unit crosssectional area, in categories of direction and energy. Based on calculations of transport through theatmosphere in an air-over-flat-ground model, these are converted to kerma in air at 1 m above ground at
various distances (“free-in-air kerma”) from the bomb hypocenters. In addition the transported fluences
are used with detailed tabulations of results from Monte Carlo calculations to calculate shielding byterrain and structures (“shielded kerma” at the survivor’s shielded location) and organ dose (absorbed
dose to a particular organ, accounting for the body’s self-shielding). RERF recently introduced a new setof dose estimates, DS02R1, based on several years’ intensive work on improving survivors’ input data on
location and shielding by vetting original source documents, using a Geographical Information System(GIS) to correct for distortions in the 1945 US Army maps that were used to record locations in map
coordinates, providing more universal and accurate terrain shielding input data from contemporary highresolution digital terrain elevation data, and correcting a number of other specific sources of inaccuracy.
The systematic differences between DS02 and DS02R1 are relatively modest, but there are more
substantial differences for individual survivors that are thought to reduce random errors. This talk will
describe the development of DS02R1 and show the differences in dose estimates as well as thecorresponding differences in risk estimates for a set of recent cancer mortality data.

Page 4 of 9

(2) Modern phantoms and their applications
W. Bolch
Advanced Laboratory for Radiation Dosimetry Studies, J. Crayton Pruitt Family Department of Biomedical Engineering
University of Florida, Gainesville, Florida 32611-6131, USA; e-mail: wbolch@ufl.edu

Abstract–Medical imaging of the infant, child, and adolescent plays an extremely important role in theoverall medical management of this critical component of the medical patient population. The vast majorityof medical images are acquired via use of ionizing radiations (photons) and thus careful optimization ofpatient radiation dose and image quality must be undertaken. Organ doses from medical imaging of thepediatric patient population are difficult to ascertain via experimental measurement, and thus one typically
employs computational anatomic models coupled to Monte Carlo radiation transport simulations. In thispresent, we will review the development of reference phantoms for the ICRP pediatric series – newborn, 1year-old, 5-year-old, 10-year-old, and 15-year-old male and female, as well as series of pregnant female
models. We will also review the use of phantom libraries that cover a broad range patient bodymorphometries such as those of the UF/NCI phantom series, which permit more detailed and patientspecific estimates of organ dose. The presentation will review techniques for organ dose assessment inthree key areas of medical imaging – computed tomography, fluoroscopy (both diagnostic andinterventional), and nuclear medical. We will discuss various studies which seek to quantity the accuracy
by which reference phantoms and phantom libraries can provide patient-specific values of internal organ
dose.

Page 5 of 9

Joint ICRP-RERF-JHPS Workshop | December 2, 2017 | Tokyo(3) Dosimetric quantities and risk
J.D. Harrison
Oxford Brookes University, Faculty of Health and Life Sciences, Oxford, OX3 0BP.
Public Health England, Centre for Radiation, Chemical and Environmental Hazards, Chilton, Oxon, OX11 0RQ.
John.harrison@phe.gov.uk

Abstract–The dosimetric quantities used in radiological protection are absorbed dose (D), with thespecial name of gray (Gy), and equivalent dose (H) and effective dose (E), both with the special name ofsievert (Sv). D is the primary scientific quantity from which E is calculated and is the most appropriatequantity for use in setting limits on organ/tissue doses to prevent tissue reactions (deterministic effects). H
to organs and tissues is obtained by multiplying organ/tissue absorbed doses by radiation weighting
factors (wR) to account for the relative effectiveness of different radiation types in causing stochastic
effects at low levels of exposure, and can be seen as an intermediate step in the calculation of E. It isargued that the current use of H to set limits to prevent tissue reactions should be discontinued. E iscalculated as the sum of organ/tissue equivalent doses multiplied by tissue weighting factors (wT) which
provide a simplified representation of fractional contributions to total stochastic detriment from cancer
and hereditary effects, expressed as sex-, age-, and population- averaged values of detriment-adjusted risk
(Sv-1). E was originally developed by ICRP for use in the radiological protection of workers and the
public. In these applications, it is used as a risk-adjusted dosimetric quantity to manage protection against
stochastic effects, comparing planned or received doses with dose limits, dose constraints, and reference
levels expressed in the same quantity. Its use allows all radiation exposures from external and internalsources to be considered together and summed, relying on the assumptions of a linear non-threshold doseresponse relationship, equivalence of acute and chronic exposures at low doses or low dose-rates, andequivalence of external and internal exposures. While age- sex-, and population- related differences inrisks per Sv are recognised, the use of constraints and reference levels that apply to all workers and all
members of the public, together with optimisation, provides a pragmatic and workable system ofprotection that does not distinguish on an individual basis. In medical applications, estimates of E are
used for comparing doses from different diagnostic and interventional imaging modalities (e.g. CT andnuclear medicine) and exposure techniques that give different spatial distributions of radiation within the
body tissues. E is used to provide a generic indicator for classifying different types of medical procedure
into broad risk categories for the purpose of communicating risks to clinicians and patients. E is also used
to inform decisions on justification of patient diagnostic and interventional procedures, planningrequirements in research studies, and evaluation of unintended exposures. Bearing in mind theuncertainties associated with risk projection to low doses or dose-rates, it is considered reasonable to use
E as an approximate indicator of possible risk in such applications, with the additional consideration ofvariation in risk with age, sex and population group. For medical procedures or other situations in which asingle radiosensitive organ receives the majority of the dose, such as the breast in mammography, or the
thyroid from therapeutic administration of iodine, mean absorbed doses to the tissues of interest should be
used rather than effective dose. The use of E as an approximate indicator of possible risk is not a
substitute for risk analysis using best estimates of organ/tissue doses, appropriate information on therelative effectiveness of different radiation types, and age- sex- and population- specific risk factors, withconsideration of uncertainties. Collective effective dose is a valuable tool in the optimisation ofprotection, particularly for occupational exposures. However, its use to predict possible health effects
should be treated with great caution, and judged in relation to background incidence rates.

Page 6 of 9

Joint ICRP-RERF-JHPS Workshop | December 2, 2017 | Tokyo(4) External doses to the public from contaminated land
D. Satoh
Nuclear Science and Engineering Center, Japan Atomic Energy Agency, Tokai-mura, Naka-gun, Ibaraki 319-1195, Japan;
e-mail: satoh.daiki@jaea.go.jp

Abstract–A significant amount of radioactive material was released into the environment by the accident
at the Fukushima Daiichi Nuclear Power Plant (Fukushima I NPP) of the Tokyo Electric Power Company
Holdings, Inc., which was caused by the Great East-Japan Earthquake and tsunami that struck Japan on
11 March 2011. The radioactive materials were widely deposited on the ground around the Fukushima I
NPP, where they elevated the radiation dose. To protect the public from radiation exposure, the effective
doses in the environment contaminated with radionuclides need to be determined. In particular, becauseof the relatively long half-lives of cesium and high energies of radiated photons, radioactive cesium (134Cs
and 137Cs) deposited on the ground after the accident is one of the most important nuclides for estimating
medium-term to long-term doses resulting from external exposure in Fukushima. Effective doses areusually estimated on the basis of measurable quantities by using conversion coefficients that arecalculated for a particular situation of each exposure. The International Commission on RadiologicalProtection (ICRP) provided a database of conversion coefficients to convert particle fluence or air kerma
to effective dose under idealized irradiation situations in the ICRP Publication 116. However, forestimating the external doses to the public from contaminated land, directly applying the data of the
Publication 116 is difficult because the radionuclides are distributed in the soil and isotropically emit
radiation. In addition, the effective doses need to be estimated from the activity concentration, personaldose equivalent Hp(10), or ambient dose equivalent H*(10) that have been measured in Fukushima. In
this work, a database of conversion coefficients to convert the activity concentration to the effective dose
rate for various ages that represent general population has been constructed for external exposure toradioactive cesium distributed in the soil, and the relationships between the personal dose equivalent rate,ambient dose equivalent rate, and effective dose rate have been analyzed. The age-dependent conversion
coefficients were calculated for planar sources of radioactive cesium at source depth of 0.0, 0.5, 2.5, 5.0,
10.0 and 50.0 g/cm2 in the soil by incorporating the ICRP reference phantoms for newborns; 1-, 5-, 10-,and 15-year-old children; and adults into the Particle and Heavy Ion Transport Code System (PHITS),
which is a Monte-Carlo simulation package. The definition of the effective dose given in the ICRP 2007
Recommendations was applied to the dose estimation not only for adults but also for children and babies
here. The personal dose equivalent rate monitored by a personal dosimeter worn on the bodies of the
public and the ambient dose equivalent rate were calculated in the same environmental radiation fields,
and were compared with the effective dose rates. From the results, it was found that the personal dose
equivalent provides a good estimate regarding the effective dose in the contaminated environment anddoes not exceed the ambient dose equivalent value at a height of 100 cm above the ground, while theeffective doses for younger people are higher than those for adults. This means that the radiation exposureof the public in Fukushima can be controlled adequately by monitoring the personal dose equivalent using
a dosimeter. In addition, the activities of the ICRP Task Group 90 for developing age-dependent
conversion coefficients for external exposure to various radionuclides in air, soil and water are also
introduced in the workshop.

Page 7 of 9

Joint ICRP-RERF-JHPS Workshop | December 2, 2017 | Tokyo(5) CT dosimetric calculator
Y. Koba
National Institute of Radiological Sciences, Center for Radiation Protection Knowledge, 4-9-1, Anagawa, Inage-ku, Chiba, 2638555 Japan; e-mail: koba.yusuke@qst.go.jp

Abstract–Recently, X-ray CT (Computed Tomography) is very popular as helpful diagnostics. But its
high exposure dose as compared with simple roentgenography should be assessed on a clinical basis as an
input to the justification and the optimization. The number of CT scanners in Japan, about 13,000, hasbeen acknowledged to be the largest over the world, as published in the reports from the OECD
(Organization for Economic Co-operation and Development) in 2014. And the number of CT scanners
per million populations is about 92; this is by far the largest. On the other hand, the number of CT
scanners in America is the second largest and is comparable with Japan, but it per million populations isabout 32. In Japan, these situations promote the dose assessment of clinical patients for justification andoptimization. WAZA-ARI is the web-based open system for CT dose calculator, which has beendeveloped by National Institute of Radiological Sciences (NIRS) and Oita University of Nursing and
Health Sciences and the Japan Atomic Energy Agency (JAEA). In WAZA-ARI version 2 (WAZAARIv2, https://waza-ari.nirs.qst.go.jp/), can provide organ doses taking into consideration of the body
type of patient using Japanese voxel phantoms developed by JAEA. And it can provide exposure dose ofchildren using child voxel phantom developed by the university of Florida. In this system selectable CT
scanners are 31 models. Number of these models account for 60% of number of CT scanner installed inJapan. We make efforts to continue increase of CT models. Furthermore, we added the database functionof storing the calculation results in each facility in order to check the exposure levels of the CT
examination in each medical facility in Japan. At January 2015, WAZA-ARIv2 system started, andcurrently over one thousand users are registered. In order to acquire more data on the actual situation of
medical exposure in Japan, we plan to expand the number of users and improve functions of WAZAARIv2 system.

Page 8 of 9

Joint ICRP-RERF-JHPS Workshop | December 2, 2017 | Tokyo(6) Modeling of internal dose from an insoluble cesium
K. Manabea, M. MatsumotobaNuclear Science and Engineering Center, Japan Atomic Energy Agency, Shirakata 2-4, Naka-gun Tokai-mura, Ibaraki-ken 3191195, Japan; e-mail: manabe.kentaro@jaea.go.jpbNational Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology,
Anagawa 4-9-1, Inage-ku, Chiba-shi, Chiba-ken 263-8555, Japan, e-mail: matsumoto.masaki@qst.go.jp

Abstract–Micrometer-sized particles bearing radioactive cesium were found after the accident ofFukushima Daiichi Nuclear Power Station. The particles were insoluble with high specific activities. If
the particle is incorporated into the human body, the radioactive cesium included in the particle will moveas a single particulate material without being distributed throughout the body by dissolving to blood ortissue fluid. Commonly applied methods for estimation of the numbers of disintegrations in organs andtissues are designed for the average behavior (i.e. distribution in the body) of countless radioactive nuclei.
Therefore, the existing methods are not applicable to the intake of the small number of cesium bearing
particles. Then, we developed a method that simulates a stochastic movement of a single particle in the
body. This stochastic biokinetic method used a compartment model based on appropriate biokinetic
models. Each retention time of the particle is determined by a random number based on the biologicalhalf-life of the compartment. If the number of the pathways from the compartment is no less than one, atarget compartment of migration of the particle is also determined by a random number based on the
proportion of the transfer coefficients from the compartment. In this way, we can track the stochastic
movement of the single particle in the body, and obtain the respective numbers of disintegrations ofradioactive cesium in the organs and tissues. Subsequently, organ absorbed doses can be evaluated bysummation of the products of the numbers of disintegrations and corresponding S values. Repetitive
execution of this procedure makes it possible to evaluate a probability density function of exposure dose.
An improved biokinetic model was also studied for micrometer-sized insoluble particles. When insoluble
particles are inhaled into the respiratory tract and deposited there, they are cleared by three main routes toblood by absorption, to alimentary tract by ciliary movement, and to regional lymphatic nodes by actionof macrophage. According to the preceding studies, some of the insoluble particulate matters aretransferred to lymphatic nodes and retained there, and the others migrate to some organs and tissues andretained, for example, liver, spleen, thymus, and so on. Considering these pathways, we constructed abiokinetic model for the cesium bearing particles based on the experimental data. In this study, theprobability density function of the absorbed dose for each target organ was evaluated by combining thestochastic biokinetic method and the biokinetic model for cesium bearing particles. In addition, the 99th
percentile, arithmetic mean and median values of the distribution of doses were compared with the dose
based on the existing models for inhalation type S which is generally applied to unknown chemical forms.
This presentation will describe the approach to modeling of the stochastic biokinetic method and the
biokinetic model for internal dosimetry of insoluble particles bearing radioactive cesium. Moreover, we
will discuss the uncertainties in the lung doses from the insolubility of particles, and also the difference ofdoses between our constructed models and the existing cesium models.

Acknowledgement: This study was conducted under the auspices of the JHPS ad-hoc committee oninternal exposures and supported by the Environment Research and Technology Development Fund of the
Ministry of the Environment (5-1501).

Page 9 of 9